A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer.

A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer. Gynecol Oncol. 2012 Sep; 126(3):369-74.

View in: PubMed

subject areas

Abdominal Abscess
Abdominal Abscess
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Anemia
Anemia
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Area Under Curve
Area Under Curve
Bevacizumab
Bevacizumab
Carboplatin
Carboplatin
Carcinoma
Carcinoma
Confidence Intervals
Confidence Intervals
Disease Progression
Disease Progression
Disease-Free Survival
Disease-Free Survival
Doxorubicin
Doxorubicin
Fallopian Tube Neoplasms
Fallopian Tube Neoplasms
Female
Female
Hand-Foot Syndrome
Hand-Foot Syndrome
Humans
Humans
Hypertension
Hypertension
Intention to Treat Analysis
Intention to Treat Analysis
Intestinal Obstruction
Intestinal Obstruction
Intestinal Perforation
Intestinal Perforation
Kaplan-Meier Estimate
Kaplan-Meier Estimate
Middle Aged
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Neoplasms, Glandular and Epithelial
Neoplasms, Glandular and Epithelial
Neutropenia
Neutropenia
Ovarian Neoplasms
Ovarian Neoplasms
Peritoneal Neoplasms
Peritoneal Neoplasms
Polyethylene Glycols
Polyethylene Glycols
Proteinuria
Proteinuria
Stomatitis
Stomatitis
Stroke Volume
Stroke Volume
Thrombocytopenia
Thrombocytopenia
Time Factors
Time Factors